Literature DB >> 21637293

Absolute requirement for STAT3 function in small-intestine crypt stem cell survival.

J R Matthews1, O J Sansom, A R Clarke.   

Abstract

The transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently activated in human cancers. Interestingly, STAT3 also maintains the pluripotency and self-renewal of murine embryonic stem cells, and several tissue stem cell types. To investigate whether STAT3 also maintains the small-intestine crypt stem cell, we conditionally inactivated a Floxed Stat3 allele (Stat3(fl)) in murine small-intestine crypt stem cells. Following Cre recombinase expression, apoptosis increased in Stat3(fl/-) experimental crypts relative to Stat3(wt/-) controls before declining. Control Stat3(wt/-) mice carrying a Flox-STOP LacZ reporter transgene stably expressed LacZ after Cre induction. In contrast, Stat3(fl/-) intestine LacZ expression initially increased modestly, before declining to background levels. Quantitative PCRs revealed a similar transient in recombined Stat3(fl) allele levels. Long-term bromodeoxyuridine labelling directly demonstrated that functional STAT3 is required for +4 to +6 region label-retaining small-intestine stem cell survival. Rapid clearance of recombined Stat3(fl/-) cells involves apoptosis potentially induced by elevated c-Myc in non-recombined cells and involves elevated p53 expression and caspase 3 activation. Intriguingly, Stat3(fl/-) intestine recombination triggered dramatically upregulated polycomb transcriptional repressor Bmi1 - potentially accelerating recombined crypt repopulation. In summary, STAT3 activity is absolutely required for small-intestine crypt stem cell survival at both the +4 to +6 label-retaining and crypt base columnar cell locations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21637293      PMCID: PMC3214915          DOI: 10.1038/cdd.2011.77

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  22 in total

1.  Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity.

Authors:  Il-Hoan Oh; Connie J Eaves
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

2.  Stem cells with multilineage potential derived from porcine skin.

Authors:  Paul W Dyce; Hai Zhu; Jesse Craig; Julang Li
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

Review 3.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

4.  Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.

Authors:  Toshiro Sato; Robert G Vries; Hugo J Snippert; Marc van de Wetering; Nick Barker; Daniel E Stange; Johan H van Es; Arie Abo; Pekka Kujala; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2009-03-29       Impact factor: 49.962

5.  Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation.

Authors:  J Lessard; A Schumacher; U Thorsteinsdottir; M van Lohuizen; T Magnuson; G Sauvageau
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

6.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types.

Authors:  H Cheng; C P Leblond
Journal:  Am J Anat       Date:  1974-12

Review 7.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin.

Authors:  Heather Ireland; Richard Kemp; Carol Houghton; Louise Howard; Alan R Clarke; Owen J Sansom; Douglas J Winton
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

9.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.

Authors:  Z Zhong; Z Wen; J E Darnell
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

10.  dMyc transforms cells into super-competitors.

Authors:  Eduardo Moreno; Konrad Basler
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

View more
  25 in total

1.  STAT3 and importins are novel mediators of early molecular and cellular responses in experimental duodenal ulceration.

Authors:  Tetyana Khomenko; Xiaoming Deng; Amrita Ahluwalia; Andrzej Tarnawski; Khushin N Patel; Zsuzsanna Sandor; Sandor Szabo
Journal:  Dig Dis Sci       Date:  2014-01-03       Impact factor: 3.199

2.  Alteration of colonic stem cell gene signatures during the regenerative response to injury.

Authors:  Laurie A Davidson; Jennifer S Goldsby; Evelyn S Callaway; Manasvi S Shah; Nick Barker; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2012-06-30

3.  IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.

Authors:  Ilona Kryczek; Yanwei Lin; Nisha Nagarsheth; Dongjun Peng; Lili Zhao; Ende Zhao; Linda Vatan; Wojciech Szeliga; Yali Dou; Scott Owens; Witold Zgodzinski; Marek Majewski; Grzegorz Wallner; Jingyuan Fang; Emina Huang; Weiping Zou
Journal:  Immunity       Date:  2014-05-08       Impact factor: 31.745

4.  IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties.

Authors:  Nasim Khosravi; Mauricio S Caetano; Amber M Cumpian; Nese Unver; Cynthia De la Garza Ramos; Oscar Noble; Soudabeh Daliri; Belinda J Hernandez; Berenice A Gutierrez; Scott E Evans; Samir Hanash; Andrei M Alekseev; Yi Yang; Seon Hee Chang; Roza Nurieva; Humam Kadara; Jichao Chen; Edwin J Ostrin; Seyed Javad Moghaddam
Journal:  Cancer Immunol Res       Date:  2018-05-15       Impact factor: 11.151

5.  Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.

Authors:  Jessica J Gierut; Priya S Mathur; Wenjun Bie; Jin Han; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2012-09-18       Impact factor: 6.261

Review 6.  Defining key concepts of intestinal and epithelial cancer biology through the use of mouse models.

Authors:  Toby J Phesse; Victoria Marsh Durban; Owen J Sansom
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

7.  Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.

Authors:  Sudha Krishnamurthy; Kristy A Warner; Zhihong Dong; Atsushi Imai; Carolina Nör; Brent B Ward; Joseph I Helman; Russell S Taichman; Emily L Bellile; Laurie K McCauley; Peter J Polverini; Mark E Prince; Max S Wicha; Jacques E Nör
Journal:  Stem Cells       Date:  2014-11       Impact factor: 6.277

8.  Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage.

Authors:  Patricia Aparicio-Domingo; Monica Romera-Hernandez; Julien J Karrich; Ferry Cornelissen; Natalie Papazian; Dicky J Lindenbergh-Kortleve; James A Butler; Louis Boon; Mark C Coles; Janneke N Samsom; Tom Cupedo
Journal:  J Exp Med       Date:  2015-09-21       Impact factor: 14.307

9.  Stat3 is required to maintain the full differentiation potential of mammary stem cells and the proliferative potential of mammary luminal progenitors.

Authors:  Anna D Staniszewska; Sara Pensa; Maria M Caffarel; Lisa H Anderson; Valeria Poli; Christine J Watson
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 10.  Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin?

Authors:  Francesco Romeo; Francesco Costanzo; Massimiliano Agostini
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.